Science Corp CEO Max Hodak is advancing a radical vision for brain-computer interfaces (BCI) that moves beyond simple electrodes toward lab-grown neural tissue and the eventual digital migration of human consciousness. While global competitors like…
Akara co-founder Conor McGinn revealed how his startup utilizes thermal sensors and artificial intelligence to reclaim up to four hours of lost operating room time daily during a recent discussion with TechCrunch AI Editor Russell…
OpenEvidence, a specialized artificial intelligence platform for healthcare professionals, has closed a $200 million funding round, propelling its market valuation to $6 billion. Led by Google Ventures, this capital surge occurs a mere three months…
Anne Wojcicki’s nonprofit organization has reached a definitive agreement to acquire 23andMe, a strategic move designed to stabilize the genetic testing pioneer as it faces a critical collapse in consumer trust. The acquisition comes at…
Medical professionals are aggressively pivoting AI integration toward administrative automation to solve the U.S. healthcare access crisis while bypassing the dangerous "hallucinations" of patient-facing chatbots. As clinical wait times soar, the industry faces a critical…
Serve Robotics is expanding its autonomous footprint by acquiring Diligent, a developer specializing in hospital assistant robots, to leverage shared software architectures and accelerate commercial scaling. CEO Ali Kashani confirmed the strategic move, noting that…
Akara, a medical technology startup, is deploying artificial intelligence and thermal sensors to reclaim up to four hours of lost productivity in hospital operating rooms (OR) every day. By automating coordination and room turnover, the…
Obvious Ventures launched its fifth investment vehicle this week, securing its status as a resilient market leader in an era where fewer than 17% of venture firms successfully raise more than three funds. This milestone…
Converge Bio, a pioneer in biological generative AI, secured $25 million in a new funding round backed by Bessemer Venture Partners and high-profile executives from OpenAI, Meta, and Wiz to replace traditional pharmaceutical trial-and-error with…
Anthropic has finalized a $400 million stock acquisition of stealth biotech AI startup Coefficient Bio, marking a significant escalation in the company's efforts to dominate the healthcare sector. The deal, reported by The Information and…
